- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01881750
Pivotal Response Group Treatment for Parents of Young Children With Autism (PRTG)
July 10, 2019 updated by: Antonio Hardan, Stanford University
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism.
Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of autism.
The purpose of this study is to further examine the effectiveness of teaching pivotal response treatment to parents of children with autism in a group format.
To determine the effectiveness of pivotal response training group (PRTG) it will be compared to another parent education group by conducting a randomized controlled 12-week trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism.
Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of autism.
Researchers have begun to develop strategies to investigate the effectiveness of teaching parents how to implement PRT in a group format, as opposed to an individual format.
Preliminary data has demonstrated that teaching PRT in a group format has shown to be effective in teaching parents and increasing children's communication skills.
The purpose of this study is to further examine the effectiveness of teaching pivotal response treatment to parents of children with autism in a group format.
To determine the effectiveness of pivotal response training group (PRTG) it will be compared to another parent education group by conducting a randomized controlled 12-week trial.
PRTG will aim to teach parents pivotal response training strategies, whereas the parent psychoeducational group (PEG) will aim to teach parents information with regards to assessment and treatment for children with autism.
By conducting this research it will improve researchers understanding of group treatment options for individuals with autism and allow us to help in the development of therapeutic approaches that can meet the increasing service demands for families.
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 6 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview - Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), and expert clinical opinion
- Outpatients between 2.0 and 6 years of age of either gender
- Children of all cognitive levels will be included as long as they are able to participate in the testing procedures to the extent that valid standard scores can be obtained
- Language delay as measured by the Preschool Language Scale 4th ed. (PLS-4)
- Participants must have the ability to make meaningful vocalizations, defined as the ability to make contingent vocalizations when prompted (i.e., vocal sound showing intent to communicate, but not necessarily clear words)
- Stable psychotropic medication(s) or biomedical interventions for at least one month prior to baseline measurements with no anticipated changes during study participation
- Stable behavioral treatment (Applied Behavioral Analysis, Floortime, or other interventions), speech therapy, and school placement for at least 2 months prior to baseline measurements with no expected changes during study participation
- No more than 60 minutes of 1:1 speech therapy per week
- The availability of at least one parent who can consistently participate in the group treatment and related activities of the research study
- Be male or female in good medical health
- Will be starting PRTG after the first magnetic resonance image (MRI) scan has occured and, if agreeable, blood draw or saliva sample
- Parents intend on continuing PRTG for a minimum of 12 weeks
- Parents must be 18 years of age or older.
Exclusion Criteria:
- A current or life-time diagnosis of severe psychiatric disorder (e.g., bipolar disorder…)
- A genetic abnormality, such as Fragile X, based on genetic testing, done as indicated
- Presence of active medical problem (e.g., unstable seizure disorder or heart disease)
- Participants taking psychotropic medications will not be included if their medications have not been stable for over a week
- Parents who do not have the ability to videotape parent and child interactions on a weekly basis
- Parents who are not willing to implement intervention strategies for at least one hour a day
- Parents who plan to alternate which parent attends the group sessions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pivotal Response Training (PRT)
12 week program on instruction of Pivotal Response Training, consisting of group meetings and individual sessions.
|
12 week program on instruction of Pivotal Response Training, consisting of group meetings and individual sessions.
|
Placebo Comparator: Parent Education Group (PEG)
12 week program consisting of offering/discussion information for parents.
No pivotal response training provided.
|
12 week program consisting of offering/discussion information for parents.
No pivotal response training provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in Communication During Structured Lab Observation (SLO) at 12 Weeks
Time Frame: Baseline, 12 weeks
|
Total frequency of child's utterances during 10 minute videotaped SLO assessment.
|
Baseline, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parenting Stress Index Total Score
Time Frame: Baseline, 12 weeks
|
Higher Scores Mean higher stress level and lower scores mean less stress (Range: Minimum = 36; Maximum=180).
|
Baseline, 12 weeks
|
Family Empowerment Scale Total Score
Time Frame: Baseline, 12 weeks
|
Higher Scores Mean better/more empowered and lower scores mean worse/less empowered (Range: Minimum = 24; Maximum=170).
|
Baseline, 12 weeks
|
Behavior Rating Inventory of Executive Function- Preschool Global Executive Composite Score
Time Frame: Baseline, 12 weeks
|
Higher scores indicate worse executive functioning and lower scores indicate better executive functioning (Range: Minimum=63; Maximum=189).
|
Baseline, 12 weeks
|
Repetitive Behavior Scale- Revised Total Score
Time Frame: Baseline, 12 weeks
|
Higher total scores mean more repetitive behaviors and lower total scores mean fewer repetitive behaviors (Range: Minimum=0; Maximum=129).
|
Baseline, 12 weeks
|
Sensory Profile Questionnaire Sensory Seeking Raw Score
Time Frame: Baseline, 12 weeks
|
Higher scores mean more typical sensory seeking behaviors and lower scores mean more abnormal sensory seeking behaviors (Range: Minimum=0; Maximum=85).
|
Baseline, 12 weeks
|
Pediatric Quality of Life Scale Scaled Total Mean Score
Time Frame: Baseline, 12 weeks
|
Higher scores mean better quality of life and lower scores mean worse quality of life (Range: Minimum=0; Maximum=100).
|
Baseline, 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hardan AY, Gengoux GW, Berquist KL, Libove RA, Ardel CM, Phillips J, Frazier TW, Minjarez MB. A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism. J Child Psychol Psychiatry. 2015 Aug;56(8):884-92. doi: 10.1111/jcpp.12354. Epub 2014 Oct 27.
- Gengoux GW, Berquist KL, Salzman E, Schapp S, Phillips JM, Frazier TW, Minjarez MB, Hardan AY. Pivotal Response Treatment Parent Training for Autism: Findings from a 3-Month Follow-Up Evaluation. J Autism Dev Disord. 2015 Sep;45(9):2889-98. doi: 10.1007/s10803-015-2452-3.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
July 20, 2011
First Submitted That Met QC Criteria
June 17, 2013
First Posted (Estimate)
June 20, 2013
Study Record Updates
Last Update Posted (Actual)
August 16, 2019
Last Update Submitted That Met QC Criteria
July 10, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-11022010-7151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autistic Disorder
-
Mahidol UniversityCompleted
-
Hadassah Medical OrganizationTerminated
-
Fundatia Bio-ForumSpitalul AngiomedicaCompletedAutistic Spectrum DisorderRomania
-
University of JazanCompletedAutistic Spectrum DisorderSaudi Arabia
-
Assistance Publique - Hôpitaux de ParisHopital Universitaire Robert-Debre; Henri Mondor University Hospital; Fondation... and other collaboratorsCompleted
-
Sutter Medical FoundationCompleted
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hospital Parc Taulí, SabadellUnknownSexual Behavior | Adolescent Development | Autistic Disorders Spectrum | Sexual InadequacySpain
-
Université de Reims Champagne-ArdenneNot yet recruitingImpact of Mixed Reality Training on Motor Skills in Children With Autistic Spectrum Disorder (RAMAu)Autistic Spectrum Disorder
-
Addis Ababa UniversityCompletedAutistic Spectrum DisorderEthiopia
Clinical Trials on Pivotal Response Training (PRT)
-
Stanford UniversityCompletedAutistic Disorder | Developmental DisabilitiesUnited States
-
Stanford UniversityAnonymous DonorRecruitingAutism Spectrum Disorder | Autism | ASDUnited States
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingAutism Spectrum Disorder | AutismUnited States
-
Stanford UniversityCompletedIntellectual Disabilities | Speech Delay | Language DisorderUnited States
-
Yale UniversityCompleted
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)RecruitingAutism Spectrum Disorder With Impaired Functional LanguageCanada
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedAutism Spectrum DisordersUnited States
-
Stanford UniversityJohn & Marcia Goldman FoundationRecruitingAutism Spectrum Disorder | AutismUnited States
-
Yale UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAutism Spectrum DisordersUnited States